Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 27, Issue 11, Pages 1396-1406Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612826666201106091527
Keywords
Hypertension; therapy; drug; intervention; novel; blood pressure
Categories
Ask authors/readers for more resources
Essential hypertension is a crucial factor in global cardiovascular diseases and mortality, highlighting the need for continuous research and development of novel agents with good tolerability to manage uncontrolled hypertension. Future strategies may involve personalized approaches and genetic modulation in the treatment of hypertension.
Essential hypertension is an important cause of cardiovascular morbidity and mortality worldwide with significant clinical and economic implications. The field of antihypertensive treatment already numbers numerous agents and classes of drugs. However, patients are still developing uncontrolled hypertension. Hence there is a continuous need for novel agents with good tolerability. Advances in this field are focusing both on pharmacotherapy, with the developments in traditional and non-traditional targets, as well as interventional techniques such as renal denervation and baroreflex activation therapy. It is likely that future strategies may involve a tailored approach to the individual patient, with genetic modulation playing a key role.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available